Last A$0.02 AUD
Change Today 0.00 / 0.00%
Volume 0.0
AVX On Other Exchanges
Symbol
Exchange
OTC US
Frankfurt
As of 9:16 PM 08/27/14 All times are local (Market data is delayed by at least 15 minutes).

avexa ltd (AVX) Snapshot

Open
A$0.02
Previous Close
A$0.02
Day High
A$0.02
Day Low
A$0.02
52 Week High
03/18/14 - A$0.03
52 Week Low
07/11/14 - A$0.01
Market Cap
13.9M
Average Volume 10 Days
253.8K
EPS TTM
A$-0.0028
Shares Outstanding
925.7M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for AVEXA LTD (AVX)

Related News

No related news articles were found.

avexa ltd (AVX) Related Businessweek News

No Related Businessweek News Found

avexa ltd (AVX) Details

Avexa Limited, a biotechnology company, discovers and develops anti-infective pharmaceutical medicines for the treatment of human infectious diseases. The company’s research programs primarily focus on the discovery of medicines for the treatment of the diseases caused by human immunodeficiency virus (HIV) and vancomycin-and methicillin-resistant bacteria. Its primary project includes apricitabine (ATC) for the treatment of drug resistant HIV, an HIV integrase program and an antibiotic program for antibiotic-resistant bacterial infections. The company was founded in 2004 and is based in Hawthorn East, Australia.

Founded in 2004

avexa ltd (AVX) Top Compensated Officers

Interim Chief Executive Officer and Chief Sci...
Total Annual Compensation: A$202.6K
Head of Finance and Financial Controller
Total Annual Compensation: A$152.0K
Head of Drug Development
Total Annual Compensation: A$166.3K
Compensation as of Fiscal Year 2014.

avexa ltd (AVX) Key Developments

Avexa Ltd., Annual General Meeting, Nov 28, 2013

Avexa Ltd., Annual General Meeting, Nov 28, 2013.

Avexa Ltd. Auditor Raises 'Going Concern' Doubt

Avexa Ltd. filed its Annual on Aug 29, 2013 for the period ending Jun 30, 2013. In this report its auditor, KPMG LLP, gave an unqualified opinion expressing doubt that the company can continue as a going concern.

Avexa Ltd. Announces Change of its Registered Address

Avexa Ltd. announced the change of its registered address to Suite 8, Level 1, 61-63 Camberwell Road, Hawthorn East, Victoria 3123. The change will take effect from 27 June 2013.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
AVX:AU A$0.02 AUD 0.00

AVX Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Bristol-Myers Squibb Co $50.50 USD -0.045
Gilead Sciences Inc $107.34 USD -0.17
Merck & Co Inc $59.92 USD -0.08
View Industry Companies
 

Industry Analysis

AVX

Industry Average

Valuation AVX Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 34.8x
Price/Book 1.1x
Price/Cash Flow NM Not Meaningful
TEV/Sales 9.8x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact AVEXA LTD, please visit www.avexa.com.au. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.